| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 9.76e-05 | 13 | 143 | 3 | GO:0005024 | |
| GeneOntologyMolecularFunction | intermediate filament binding | 1.54e-04 | 15 | 143 | 3 | GO:0019215 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.64e-04 | 85 | 143 | 5 | GO:0019199 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 3.75e-04 | 20 | 143 | 3 | GO:0004675 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 1.60e-05 | 161 | 142 | 8 | GO:0003231 | |
| GeneOntologyBiologicalProcess | tricuspid valve morphogenesis | 1.74e-05 | 8 | 142 | 3 | GO:0003186 | |
| GeneOntologyBiologicalProcess | tricuspid valve development | 2.60e-05 | 9 | 142 | 3 | GO:0003175 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 3.95e-05 | 91 | 142 | 6 | GO:0003281 | |
| GeneOntologyBiologicalProcess | sensory organ development | NPHP1 GPD2 NES BNC2 FAT3 RET SIX4 TGFBR2 CRYBB3 KMT2C MYO3A BMPR2 GLI2 RP1L1 PCDH15 C3 | 4.41e-05 | 730 | 142 | 16 | GO:0007423 |
| GeneOntologyBiologicalProcess | notochord regression | 4.71e-05 | 2 | 142 | 2 | GO:0060032 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.13e-04 | 212 | 142 | 8 | GO:0003205 | |
| GeneOntologyBiologicalProcess | negative regulation of Rho-dependent protein serine/threonine kinase activity | 1.41e-04 | 3 | 142 | 2 | GO:2000299 | |
| GeneOntologyBiologicalProcess | neuron development | NPHP1 MAP1B TRIO FAT3 TSC2 BCAN RET ZNF804A TIAM2 SYNGAP1 NEK3 MYO3A BMPR2 GLI2 CNTN5 DHFR RP1L1 PCDH15 KNDC1 IGSF9 C3 SAMD14 EPHA5 | 1.63e-04 | 1463 | 142 | 23 | GO:0048666 |
| GeneOntologyBiologicalProcess | developmental growth | GPD2 BNC2 MAP1B CTC1 BCAN SIX4 ZFPM2 TGFBR2 KMT2C BMPR2 HEG1 CCM2L GLI1 GLI2 MTM1 PCDH15 C3 | 1.80e-04 | 911 | 142 | 17 | GO:0048589 |
| GeneOntologyBiologicalProcess | camera-type eye development | 1.81e-04 | 426 | 142 | 11 | GO:0043010 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | NES MAP1B TRIO FAT3 TSC2 BCAN RET TIAM2 SYNGAP1 NEK3 MYO3A BMPR2 HEG1 P2RX7 GLI2 CNTN5 PCDH15 KNDC1 IGSF9 EPHA5 | 2.00e-04 | 1194 | 142 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | MAP1B TRIO FAT3 TSC2 RET TIAM2 SYNGAP1 MYO3A BMPR2 GLI2 CNTN5 PCDH15 KNDC1 IGSF9 EPHA5 | 2.05e-04 | 748 | 142 | 15 | GO:0048667 |
| GeneOntologyCellularComponent | dendrite | CACNA1B MAP1B FAT3 KIF1B ARFGEF2 TSC2 BCAN RET ZNF804A ZWINT SYNGAP1 BMPR2 KNDC1 IGSF9 LTBP1 SAMD14 EPHA5 | 8.14e-05 | 858 | 143 | 17 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CACNA1B MAP1B FAT3 KIF1B ARFGEF2 TSC2 BCAN RET ZNF804A ZWINT SYNGAP1 BMPR2 KNDC1 IGSF9 LTBP1 SAMD14 EPHA5 | 8.38e-05 | 860 | 143 | 17 | GO:0097447 |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1B MAP1B FAT3 KIF1B ARFGEF2 TSC2 BCAN RET ZNF804A TIAM2 ZWINT SYNGAP1 BMPR2 OPTN P2RX7 KNDC1 IGSF9 LTBP1 SAMD14 EPHA5 | 2.67e-04 | 1228 | 143 | 20 | GO:0036477 |
| GeneOntologyCellularComponent | GLI-SUFU complex | 2.76e-04 | 4 | 143 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | axon | CACNA1B LDLRAP1 MAP1B KIF1B TSC2 BCAN RET ZNF804A TIAM2 NEK3 BMPR2 OPTN P2RX7 CNTN5 IGSF9 EPHA5 | 4.02e-04 | 891 | 143 | 16 | GO:0030424 |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 6.53e-04 | 153 | 143 | 6 | GO:0097731 | |
| Domain | - | 7.79e-06 | 222 | 142 | 10 | 1.25.10.10 | |
| Domain | ARM-like | 4.20e-05 | 270 | 142 | 10 | IPR011989 | |
| Domain | DNase_TatD-rel_CS | 5.74e-05 | 2 | 142 | 2 | IPR018228 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 5.74e-05 | 2 | 142 | 2 | IPR013037 | |
| Domain | - | 5.74e-05 | 2 | 142 | 2 | 2.60.40.1150 | |
| Domain | PH | 6.51e-05 | 229 | 142 | 9 | PF00169 | |
| Domain | TatD_DNase | 1.71e-04 | 3 | 142 | 2 | PF01026 | |
| Domain | AP_complex_bsu_1_2_4 | 1.71e-04 | 3 | 142 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 1.71e-04 | 3 | 142 | 2 | PF09066 | |
| Domain | TATD_2 | 1.71e-04 | 3 | 142 | 2 | PS01090 | |
| Domain | TATD_3 | 1.71e-04 | 3 | 142 | 2 | PS01091 | |
| Domain | TatD_family | 1.71e-04 | 3 | 142 | 2 | IPR001130 | |
| Domain | - | LDLRAP1 TRIO KIF1B SH2B1 TIAM2 SYNGAP1 SPTBN5 OSBP MTM1 APPL1 CYTH4 | 2.02e-04 | 391 | 142 | 11 | 2.30.29.30 |
| Domain | ARM-type_fold | 2.72e-04 | 339 | 142 | 10 | IPR016024 | |
| Domain | PH | 2.81e-04 | 278 | 142 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 2.88e-04 | 279 | 142 | 9 | PS50003 | |
| Domain | PH_domain | 2.96e-04 | 280 | 142 | 9 | IPR001849 | |
| Domain | B2-adapt-app_C | 3.41e-04 | 4 | 142 | 2 | SM01020 | |
| Domain | B-adaptin_app_sub_C | 3.41e-04 | 4 | 142 | 2 | IPR015151 | |
| Domain | PH_dom-like | LDLRAP1 TRIO KIF1B SH2B1 TIAM2 SYNGAP1 SPTBN5 OSBP MTM1 APPL1 CYTH4 | 4.20e-04 | 426 | 142 | 11 | IPR011993 |
| Domain | Armadillo | 4.43e-04 | 47 | 142 | 4 | IPR000225 | |
| Domain | FYrich_C | 5.65e-04 | 5 | 142 | 2 | IPR003889 | |
| Domain | FYrich_N | 5.65e-04 | 5 | 142 | 2 | IPR003888 | |
| Domain | AP_beta | 5.65e-04 | 5 | 142 | 2 | IPR026739 | |
| Domain | FYRC | 5.65e-04 | 5 | 142 | 2 | SM00542 | |
| Domain | FYRN | 5.65e-04 | 5 | 142 | 2 | SM00541 | |
| Domain | FYRN | 5.65e-04 | 5 | 142 | 2 | PF05964 | |
| Domain | FYRC | 5.65e-04 | 5 | 142 | 2 | PF05965 | |
| Domain | FYRC | 5.65e-04 | 5 | 142 | 2 | PS51543 | |
| Domain | FYRN | 5.65e-04 | 5 | 142 | 2 | PS51542 | |
| Domain | Beta2_adaptin/TBP_C_dom | 8.44e-04 | 6 | 142 | 2 | IPR012295 | |
| Domain | - | 8.44e-04 | 6 | 142 | 2 | 3.30.310.10 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.56e-03 | 8 | 142 | 2 | IPR009028 | |
| Domain | Alpha_adaptinC2 | 2.00e-03 | 9 | 142 | 2 | PF02883 | |
| Domain | ZF_SWIM | 2.00e-03 | 9 | 142 | 2 | PS50966 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 2.00e-03 | 9 | 142 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 2.00e-03 | 9 | 142 | 2 | SM00809 | |
| Domain | Znf_SWIM | 2.00e-03 | 9 | 142 | 2 | IPR007527 | |
| Domain | ARM | 3.46e-03 | 40 | 142 | 3 | SM00185 | |
| Domain | TGFB_receptor | 3.60e-03 | 12 | 142 | 2 | IPR000333 | |
| Domain | Coatomer/clathrin_app_Ig-like | 3.60e-03 | 12 | 142 | 2 | IPR013041 | |
| Domain | PDZ | 4.48e-03 | 141 | 142 | 5 | PF00595 | |
| Domain | PDZ | 5.49e-03 | 148 | 142 | 5 | SM00228 | |
| Domain | Clathrin/coatomer_adapt-like_N | 5.65e-03 | 15 | 142 | 2 | IPR002553 | |
| Domain | Adaptin_N | 5.65e-03 | 15 | 142 | 2 | PF01602 | |
| Domain | - | 5.65e-03 | 15 | 142 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 5.65e-03 | 15 | 142 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 5.65e-03 | 15 | 142 | 2 | IPR023394 | |
| Domain | - | 5.81e-03 | 150 | 142 | 5 | 2.30.42.10 | |
| Domain | PDZ | 5.97e-03 | 151 | 142 | 5 | PS50106 | |
| Domain | PDZ | 6.14e-03 | 152 | 142 | 5 | IPR001478 | |
| Domain | Post-SET_dom | 6.42e-03 | 16 | 142 | 2 | IPR003616 | |
| Domain | PostSET | 6.42e-03 | 16 | 142 | 2 | SM00508 | |
| Domain | SEC7 | 6.42e-03 | 16 | 142 | 2 | PS50190 | |
| Domain | Sec7 | 6.42e-03 | 16 | 142 | 2 | SM00222 | |
| Domain | Sec7_dom | 6.42e-03 | 16 | 142 | 2 | IPR000904 | |
| Domain | POST_SET | 6.42e-03 | 16 | 142 | 2 | PS50868 | |
| Domain | EF-hand-dom_pair | 6.43e-03 | 287 | 142 | 7 | IPR011992 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RHBDF1 KMT2B ZNF628 TRIO VWA8 CTC1 RTTN HECTD4 ARFGEF2 TSC2 SLC29A2 TIAM2 KMT2C HEG1 BTBD7 GLI1 HERC2 ESPL1 DOCK6 CYTH4 TJP3 HR | 1.49e-09 | 1105 | 146 | 22 | 35748872 |
| Pubmed | 4.53e-07 | 222 | 146 | 9 | 37071664 | ||
| Pubmed | SUMOylation by Pias1 regulates the activity of the Hedgehog dependent Gli transcription factors. | 7.20e-07 | 5 | 146 | 3 | 20711444 | |
| Pubmed | NES ZSWIM8 MAP1B UGGT1 MCM6 ZNF318 HEATR1 RIF1 AP1B1 RNH1 AP2B1 HERC2 COIL ANKRD52 | 7.30e-07 | 653 | 146 | 14 | 22586326 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | VWA8 TNPO2 PPP1R12B UGGT1 MYO18A ZYG11B ZNF318 HEATR1 CHORDC1 ZWINT RNH1 CEP112 HERC2 DOCK6 | 3.89e-06 | 754 | 146 | 14 | 33060197 |
| Pubmed | Neural Hedgehog signaling maintains stem cell renewal in the sensory touch dome epithelium. | 4.00e-06 | 8 | 146 | 3 | 26015562 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B BCLAF1 KIF1B MYO18A ARFGEF2 TATDN2 ZNF318 RIF1 OSBP MYO3A APPL1 COIL ESPL1 CYTH4 | 5.24e-06 | 774 | 146 | 14 | 15302935 |
| Pubmed | The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. | 5.98e-06 | 9 | 146 | 3 | 11748155 | |
| Pubmed | Interplays of Gli2 and Gli3 and their requirement in mediating Shh-dependent sclerotome induction. | 8.51e-06 | 10 | 146 | 3 | 14602680 | |
| Pubmed | 8.51e-06 | 10 | 146 | 3 | 19842175 | ||
| Pubmed | 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in. | 1.17e-05 | 11 | 146 | 3 | 30022158 | |
| Pubmed | 1.30e-05 | 335 | 146 | 9 | 15741177 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | GPD2 NES MAP1B VWA8 BCLAF1 HECTD4 MYO18A SIM1 SYNGAP1 ZNF462 AP2B1 EIF2S1 PCDH15 CKAP4 COIL DOCK6 | 1.36e-05 | 1082 | 146 | 16 | 38697112 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | LDLRAP1 RET ZNF804A PIAS1 SH2B1 PRX SYNGAP1 GUCY1B2 AP2B1 GLI2 | 1.49e-05 | 430 | 146 | 10 | 35044719 |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 33125874 | ||
| Pubmed | Maintenance of Taste Organs Is Strictly Dependent on Epithelial Hedgehog/GLI Signaling. | 1.75e-05 | 2 | 146 | 2 | 27893742 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 32997394 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 32745914 | ||
| Pubmed | RIF1 counteracts BRCA1-mediated end resection during DNA repair. | 1.75e-05 | 2 | 146 | 2 | 23486525 | |
| Pubmed | MYO3A Causes Human Dominant Deafness and Interacts with Protocadherin 15-CD2 Isoform. | 1.75e-05 | 2 | 146 | 2 | 26841241 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 28439082 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 25745035 | ||
| Pubmed | Unique and overlapping GLI1 and GLI2 transcriptional targets in neoplastic chondrocytes. | 1.75e-05 | 2 | 146 | 2 | 30695055 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 30741587 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 25762631 | ||
| Pubmed | Human GLI2 and GLI1 are part of a positive feedback mechanism in Basal Cell Carcinoma. | 1.75e-05 | 2 | 146 | 2 | 12165851 | |
| Pubmed | The GLI gene is a member of the Kruppel family of zinc finger proteins. | 1.75e-05 | 2 | 146 | 2 | 2832761 | |
| Pubmed | GLI1/GLI2 functional interplay is required to control Hedgehog/GLI targets gene expression. | 1.75e-05 | 2 | 146 | 2 | 32766732 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 35251038 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 15175043 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 32604168 | ||
| Pubmed | [Expression and clinical significances of hedgehog signaling pathway in non-Hodgkin's lymphoma]. | 1.75e-05 | 2 | 146 | 2 | 22040957 | |
| Pubmed | ARH cooperates with AP-1B in the exocytosis of LDLR in polarized epithelial cells. | 1.75e-05 | 2 | 146 | 2 | 21444685 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 23792444 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 31905741 | ||
| Pubmed | SH2B1beta adaptor is a key enhancer of RET tyrosine kinase signaling. | 1.75e-05 | 2 | 146 | 2 | 17471236 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 35418691 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 24418624 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 25692141 | ||
| Pubmed | Overlapping and distinct transcriptional regulator properties of the GLI1 and GLI2 oncogenes. | 1.75e-05 | 2 | 146 | 2 | 16434164 | |
| Pubmed | 2.01e-05 | 13 | 146 | 3 | 34210780 | ||
| Pubmed | Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. | 2.19e-05 | 39 | 146 | 4 | 25944111 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | GPD2 NES MAP1B BCLAF1 UGGT1 MCM6 LRRC40 ZNF318 HEATR1 RIF1 EIF2S1 PKP1 CKAP4 HERC2 COIL | 2.87e-05 | 1024 | 146 | 15 | 24711643 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.97e-05 | 208 | 146 | 7 | 33230847 | |
| Pubmed | 3.15e-05 | 288 | 146 | 8 | 23383273 | ||
| Pubmed | Gli2 and Gli3 have redundant and context-dependent function in skeletal muscle formation. | 3.18e-05 | 15 | 146 | 3 | 15604102 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | ZSWIM8 ATG16L1 BCLAF1 MTFR1L CDC7 AP1B1 AP2B1 EIF2S1 BTBD7 KNDC1 COIL ESPL1 DOCK6 ANKRD52 TJP3 | 3.35e-05 | 1038 | 146 | 15 | 26673895 |
| Pubmed | 3.90e-05 | 16 | 146 | 3 | 9655799 | ||
| Pubmed | 3.90e-05 | 16 | 146 | 3 | 29764992 | ||
| Pubmed | 3.90e-05 | 16 | 146 | 3 | 17638910 | ||
| Pubmed | 4.72e-05 | 17 | 146 | 3 | 21289193 | ||
| Pubmed | KIF1B ZNF318 SIX4 SIM1 PIAS1 ZNF462 KMT2C BRCA1 GLI1 GLI2 NCOA1 PLAGL2 | 4.81e-05 | 709 | 146 | 12 | 22988430 | |
| Pubmed | Direct repression of anoctamin 1 (ANO1) gene transcription by Gli proteins. | 5.24e-05 | 3 | 146 | 2 | 30802137 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 26010061 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 28342001 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 34630143 | ||
| Pubmed | The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer. | 5.24e-05 | 3 | 146 | 2 | 30382189 | |
| Pubmed | The effect of C1 inhibitor on intestinal ischemia and reperfusion injury. | 5.24e-05 | 3 | 146 | 2 | 18787060 | |
| Pubmed | Effect of Rab23 on the proliferation and apoptosis in breast cancer. | 5.24e-05 | 3 | 146 | 2 | 26238143 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 37541211 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 26193634 | ||
| Pubmed | The mechanism of epithelial-mesenchymal transition induced by TGF-β1 in neuroblastoma cells. | 5.24e-05 | 3 | 146 | 2 | 28393230 | |
| Pubmed | TGF-β1 promotes cerebral cortex radial glia-astrocyte differentiation in vivo. | 5.24e-05 | 3 | 146 | 2 | 25484855 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 18563714 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 27759030 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 24217340 | ||
| Pubmed | Gli family members are differentially expressed during the mitotic phase of spermatogenesis. | 5.24e-05 | 3 | 146 | 2 | 9178901 | |
| Pubmed | Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers. | 5.24e-05 | 3 | 146 | 2 | 8378770 | |
| Pubmed | Effect of interferon-gamma on complement gene expression in different cell types. | 5.24e-05 | 3 | 146 | 2 | 1531292 | |
| Pubmed | The effects of Gli1 and Gli2 on BMP9-induced osteogenic differentiation of mesenchymal stem cells. | 5.24e-05 | 3 | 146 | 2 | 37478645 | |
| Pubmed | Transforming growth factor-beta receptors interact with AP2 by direct binding to beta2 subunit. | 5.24e-05 | 3 | 146 | 2 | 12429842 | |
| Pubmed | Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma. | 5.24e-05 | 3 | 146 | 2 | 32108992 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 25888497 | ||
| Pubmed | ZGRF1 promotes end resection of DNA homologous recombination via forming complex with BRCA1/EXO1. | 5.24e-05 | 3 | 146 | 2 | 34552057 | |
| Pubmed | Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG. | 5.24e-05 | 3 | 146 | 2 | 33313950 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 8387379 | ||
| Pubmed | Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling. | 5.24e-05 | 3 | 146 | 2 | 16571352 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 12068298 | ||
| Pubmed | Different expression patterns of Gli1-3 in mouse embryonic maxillofacial development. | 5.24e-05 | 3 | 146 | 2 | 22178118 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 23178452 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 32879407 | ||
| Pubmed | Gli1 is important for medulloblastoma formation in Ptc1+/- mice. | 5.24e-05 | 3 | 146 | 2 | 15806168 | |
| Pubmed | TUSC4 functions as a tumor suppressor by regulating BRCA1 stability. | 5.24e-05 | 3 | 146 | 2 | 25480944 | |
| Pubmed | SOX18 Is a Novel Target Gene of Hedgehog Signaling in Cervical Carcinoma Cell Lines. | 5.24e-05 | 3 | 146 | 2 | 26588701 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 20631078 | ||
| Pubmed | VWA8 UGGT1 MCM6 TSC2 HEATR1 MTFR1L CDC7 RIF1 DHFR HERC2 ANKRD52 | 5.39e-05 | 606 | 146 | 11 | 36538041 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ABAT MAP1B TRIO KIF1B AFF3 HECTD4 SH2B1 ZNF462 KMT2C BMPR2 PTPRR GLI2 KNDC1 IGSF9 DOCK6 TATDN1 CLBA1 PDZD2 | 5.56e-05 | 1489 | 146 | 18 | 28611215 |
| Pubmed | 5.65e-05 | 18 | 146 | 3 | 23211419 | ||
| Pubmed | NES TRIO BCLAF1 HECTD4 TSC2 ZNF318 SYNGAP1 ZNF462 AP1B1 P2RX7 AP2B1 PPP1R3F APPL1 HERC2 | 5.81e-05 | 963 | 146 | 14 | 28671696 | |
| Pubmed | KMT2B BAZ2B BCLAF1 TNPO2 ZNF318 PSME2 PIAS1 KMT2C BRCA1 AP1B1 RNH1 AP2B1 EIF2S1 NCOA1 PLAGL2 | 6.64e-05 | 1103 | 146 | 15 | 34189442 | |
| Pubmed | APC sets the Wnt tone necessary for cerebral cortical progenitor development. | 6.68e-05 | 19 | 146 | 3 | 28916710 | |
| Pubmed | alphaE-catenin controls cerebral cortical size by regulating the hedgehog signaling pathway. | 6.68e-05 | 19 | 146 | 3 | 16543460 | |
| Pubmed | A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients. | 9.12e-05 | 21 | 146 | 3 | 24025145 | |
| Pubmed | 9.12e-05 | 21 | 146 | 3 | 29945868 | ||
| Pubmed | CACNA1B ABAT MAP1B TRIO VWA8 BCLAF1 MYO18A ZWINT SYNGAP1 OSBP KNDC1 PKP1 APPL1 CKAP4 COIL | 9.48e-05 | 1139 | 146 | 15 | 36417873 | |
| Pubmed | Protein phosphatase 1γ isoforms linked interactions in the brain. | 9.90e-05 | 57 | 146 | 4 | 23080069 | |
| Pubmed | ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. | 9.90e-05 | 57 | 146 | 4 | 23788249 | |
| Pubmed | Crucial roles for interactions between MLL3/4 and INI1 in nuclear receptor transactivation. | 1.04e-04 | 4 | 146 | 2 | 19221051 | |
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 9027508 | ||
| Pubmed | 1.04e-04 | 4 | 146 | 2 | 22281533 | ||
| GeneFamily | Cadherin related | 8.78e-05 | 17 | 94 | 3 | 24 | |
| GeneFamily | Type 2 receptor serine/threonine kinases | 2.65e-04 | 5 | 94 | 2 | 346 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.20e-04 | 206 | 94 | 6 | 682 | |
| GeneFamily | Zinc fingers SWIM-type|Mitogen-activated protein kinase kinase kinases | 9.40e-04 | 9 | 94 | 2 | 90 | |
| GeneFamily | PDZ domain containing | 1.18e-03 | 152 | 94 | 5 | 1220 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.55e-03 | 181 | 94 | 5 | 694 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.96e-06 | 180 | 146 | 8 | M8239 | |
| Coexpression | GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 1.54e-05 | 197 | 146 | 8 | M8980 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.59e-05 | 198 | 146 | 8 | M8624 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NPHP1 CACNA1B ABAT CTC1 ZGRF1 MCM6 LRRC40 SIX4 CDC7 GREB1L RIF1 GALNT9 DHFR SAMD14 | 2.83e-05 | 680 | 146 | 14 | MM456 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-08 | 196 | 146 | 9 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | IPF-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.82e-08 | 196 | 146 | 9 | 8f0f72ead06abe02b575e443552eacc2151077ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.82e-08 | 196 | 146 | 9 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Capillary|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.16e-08 | 200 | 146 | 9 | 6c0498a5868891e8e22c03469d00669b20249b1a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.16e-08 | 200 | 146 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.16e-08 | 200 | 146 | 9 | 7020045b933cb104fb99b79524cb0d4734b8636d | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Capillary|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.16e-08 | 200 | 146 | 9 | e9913511a129bb3cee85e7ebf565b951dab91542 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.62e-07 | 194 | 146 | 8 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-07 | 195 | 146 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-07 | 195 | 146 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-07 | 196 | 146 | 8 | d323f7dc41380446e5967c69832bea88351a9331 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-07 | 199 | 146 | 8 | bff61a784ef8bc040f5c7baabccaf7a7cddd5a31 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-07 | 199 | 146 | 8 | 8b62d43af8b2ebb4c1b2d068d50beaf35728dbe7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-07 | 199 | 146 | 8 | da5a88749d859d535daa030d0974485906cc0ba7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.18e-07 | 199 | 146 | 8 | 3cb1d9d9de64ed0a56c4f8d5e2fa02a13a73d8ac | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 9.69e-07 | 159 | 146 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.24e-06 | 165 | 146 | 7 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.29e-06 | 166 | 146 | 7 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.98e-06 | 177 | 146 | 7 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-06 | 178 | 146 | 7 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.06e-06 | 178 | 146 | 7 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.22e-06 | 180 | 146 | 7 | 544fb373a3346186ec60afe2cfcf141bb04a1eed | |
| ToppCell | COVID-19-Endothelial_cells-Capillary_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.30e-06 | 181 | 146 | 7 | c5f9c92af1384d9089c65afdf41c6feb8345a3ae | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.96e-06 | 188 | 146 | 7 | c9270517e6940e9793586f67f02431210552f278 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 189 | 146 | 7 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.06e-06 | 189 | 146 | 7 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-06 | 190 | 146 | 7 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 191 | 146 | 7 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 3.64e-06 | 194 | 146 | 7 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.76e-06 | 195 | 146 | 7 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.89e-06 | 196 | 146 | 7 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.02e-06 | 197 | 146 | 7 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.16e-06 | 198 | 146 | 7 | 55378e15360f867c9500b03293814965562ae55d | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35|World / Primary Cells by Cluster | 4.16e-06 | 198 | 146 | 7 | de5214a85fe017eb23d4aa8af624464f062ec57e | |
| ToppCell | (6)_Endothelial-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.16e-06 | 198 | 146 | 7 | a5e1b321376caf262ea48904d31afd1b8e9d3be2 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.30e-06 | 199 | 146 | 7 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.30e-06 | 199 | 146 | 7 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.30e-06 | 199 | 146 | 7 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.30e-06 | 199 | 146 | 7 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.30e-06 | 199 | 146 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.44e-06 | 200 | 146 | 7 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.44e-06 | 200 | 146 | 7 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-06 | 200 | 146 | 7 | dba96cda5f3b780a3d4171b61bc8aaddc1f5d466 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-06 | 200 | 146 | 7 | 2e47888e041ec3d265425d1df97b6665c6da889c | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-06 | 200 | 146 | 7 | 50fa0f8a3e490d5941b34e66a10158eba6c909d4 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-06 | 200 | 146 | 7 | ced14d83222dbebca85c40540e76824e683354f3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-06 | 200 | 146 | 7 | 7a69ad5b6c84f1aebacea5cacb9bc5c63dfd1dac | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.44e-06 | 200 | 146 | 7 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 162 | 146 | 6 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.59e-05 | 162 | 146 | 6 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 164 | 146 | 6 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 167 | 146 | 6 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.95e-05 | 168 | 146 | 6 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.02e-05 | 169 | 146 | 6 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 176 | 146 | 6 | 116741fef5895ca85057d2d31eca9eba5764ab44 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 176 | 146 | 6 | 5b707f58d164ee7a6a527dd5d053472ce9a631c1 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.62e-05 | 177 | 146 | 6 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-05 | 178 | 146 | 6 | c77a1d1a9aef0ab51b4408b9e84f201219788ca2 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.79e-05 | 179 | 146 | 6 | e1bfd553c043ebc070ccf8545d489ba16d9b2ef4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-05 | 179 | 146 | 6 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.88e-05 | 180 | 146 | 6 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.88e-05 | 180 | 146 | 6 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.97e-05 | 181 | 146 | 6 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.97e-05 | 181 | 146 | 6 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.06e-05 | 182 | 146 | 6 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 3.16e-05 | 183 | 146 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.16e-05 | 183 | 146 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.25e-05 | 184 | 146 | 6 | fa38d6a8709f520a027ad7e3ff783c84187ec467 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 3.25e-05 | 184 | 146 | 6 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 3.35e-05 | 185 | 146 | 6 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-05 | 185 | 146 | 6 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 3.35e-05 | 185 | 146 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.56e-05 | 187 | 146 | 6 | 37d8ee5c8bd6324749e5a2adef1d0482c75da80c | |
| ToppCell | 3'-Adult-Appendix-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.56e-05 | 187 | 146 | 6 | ec98d5e480b08854dfd0ba6b1dc6610455f90640 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.67e-05 | 188 | 146 | 6 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D122|Adult / Lineage, Cell type, age group and donor | 3.67e-05 | 188 | 146 | 6 | 02a62888e9db29d20133eeca1686d302545a39c9 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.67e-05 | 188 | 146 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | COPD-Epithelial-Mesothelial|Epithelial / Disease state, Lineage and Cell class | 3.67e-05 | 188 | 146 | 6 | 159d63ecc3653a7449fc6acefd6ef0464845260e | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 3.78e-05 | 189 | 146 | 6 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.78e-05 | 189 | 146 | 6 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 189 | 146 | 6 | 6f0fc5271a7d3682f145e734abc3be6473dda2e2 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.78e-05 | 189 | 146 | 6 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 189 | 146 | 6 | 3b9ce8964b16cb2200d30cbb0bfc711dcad2380e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 189 | 146 | 6 | 38acb307907fde68b992057714448c1561d69ee3 | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Up 200; 13.8uM; PC3; HT_HG-U133A | 4.85e-06 | 195 | 146 | 9 | 4298_UP | |
| Drug | Rimexolone [49697-38-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 5.72e-06 | 199 | 146 | 9 | 5517_DN | |
| Disease | Colorectal Carcinoma | EVC2 MAP1B ZBTB8B RET ITPRID1 ZNF804A TGFBR2 KMT2C OSBP P2RX7 CCDC62 DHFR HR | 4.25e-05 | 702 | 144 | 13 | C0009402 |
| Disease | Intellectual Disability | CACNA1B MAP1B TRIO RTTN AFF3 SYNGAP1 ZNF462 KMT2C BRCA1 AP1B1 | 7.27e-05 | 447 | 144 | 10 | C3714756 |
| Disease | Ellis-Van Creveld Syndrome | 1.41e-04 | 4 | 144 | 2 | C0013903 | |
| Disease | vascular endothelial growth factor measurement | 1.64e-04 | 56 | 144 | 4 | EFO_0004762 | |
| Disease | Congenital absence of kidneys syndrome | 2.34e-04 | 5 | 144 | 2 | C1609433 | |
| Disease | Malignant neoplasm of breast | C1orf87 PPP1R12B ARFGEF2 ZNF318 SIX4 SIM1 RIF1 BMPR2 BRCA1 GLI1 DHFR NCOA1 APPL1 HERC2 RMND1 | 2.54e-04 | 1074 | 144 | 15 | C0006142 |
| Disease | periventricular nodular heterotopia (is_implicated_in) | 3.50e-04 | 6 | 144 | 2 | DOID:0050454 (is_implicated_in) | |
| Disease | lysosomal protective protein measurement | 4.89e-04 | 7 | 144 | 2 | EFO_0008215 | |
| Disease | acute myocardial infarction (is_marker_for) | 4.89e-04 | 7 | 144 | 2 | DOID:9408 (is_marker_for) | |
| Disease | Periventricular Nodular Heterotopia | 4.89e-04 | 7 | 144 | 2 | C1868720 | |
| Disease | Unilateral agenesis of kidney | 6.50e-04 | 8 | 144 | 2 | C0266294 | |
| Disease | Dickkopf-related protein 4 measurement | 6.50e-04 | 8 | 144 | 2 | EFO_0008110 | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 8.33e-04 | 9 | 144 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | lifestyle measurement | 1.07e-03 | 235 | 144 | 6 | EFO_0010724 | |
| Disease | Squamous cell carcinoma of esophagus | 1.23e-03 | 95 | 144 | 4 | C0279626 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 1.26e-03 | 11 | 144 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | nucleus accumbens volume change measurement | 1.26e-03 | 11 | 144 | 2 | EFO_0021493 | |
| Disease | mean platelet volume | LDLRAP1 PCDHGA3 KIF1B RTTN AFF3 ZFPM2 AP1B1 AP2B1 CCDC62 GALNT9 SERPING1 LTBP1 ESPL1 | 1.51e-03 | 1020 | 144 | 13 | EFO_0004584 |
| Disease | Gastrointestinal Stromal Sarcoma | 1.58e-03 | 47 | 144 | 3 | C3179349 | |
| Disease | Leukemia, Myelocytic, Acute | 1.63e-03 | 173 | 144 | 5 | C0023467 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.78e-03 | 13 | 144 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | immature platelet count | 1.84e-03 | 106 | 144 | 4 | EFO_0803544 | |
| Disease | Gastrointestinal Stromal Tumors | 1.89e-03 | 50 | 144 | 3 | C0238198 | |
| Disease | actinic keratosis | 2.07e-03 | 14 | 144 | 2 | EFO_0002496 | |
| Disease | Ciliopathies | 2.10e-03 | 110 | 144 | 4 | C4277690 | |
| Disease | wellbeing measurement | BNC2 BAZ2B ARFGEF2 SIM1 ZNF804A TGFBR2 PTPRR CEP112 CNTN5 RP1L1 | 2.18e-03 | 692 | 144 | 10 | EFO_0007869 |
| Disease | immature platelet fraction | 2.40e-03 | 114 | 144 | 4 | EFO_0009187 | |
| Disease | Drug habituation | 2.47e-03 | 115 | 144 | 4 | C0013170 | |
| Disease | Drug abuse | 2.47e-03 | 115 | 144 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.47e-03 | 115 | 144 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 2.47e-03 | 115 | 144 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 2.47e-03 | 115 | 144 | 4 | C0013222 | |
| Disease | Drug Dependence | 2.47e-03 | 115 | 144 | 4 | C1510472 | |
| Disease | Substance Dependence | 2.47e-03 | 115 | 144 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 2.47e-03 | 115 | 144 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.47e-03 | 115 | 144 | 4 | C0029231 | |
| Disease | factor VII measurement | 2.48e-03 | 55 | 144 | 3 | EFO_0004619 | |
| Disease | Substance abuse problem | 2.55e-03 | 116 | 144 | 4 | C0740858 | |
| Disease | Pheochromocytoma, Extra-Adrenal | 2.71e-03 | 16 | 144 | 2 | C1257877 | |
| Disease | immature platelet measurement | 2.80e-03 | 119 | 144 | 4 | EFO_0803541 | |
| Disease | ocular hypertension (biomarker_via_orthology) | 3.07e-03 | 17 | 144 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | S-adenosylhomocysteine measurement | 3.07e-03 | 17 | 144 | 2 | EFO_0010531 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.07e-03 | 17 | 144 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 3.83e-03 | 19 | 144 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | Pheochromocytoma | 3.83e-03 | 19 | 144 | 2 | C0031511 | |
| Disease | retinal vasculature measurement | 3.98e-03 | 517 | 144 | 8 | EFO_0010554 | |
| Disease | Global developmental delay | 4.17e-03 | 133 | 144 | 4 | C0557874 | |
| Disease | Mammary Neoplasms | 4.46e-03 | 527 | 144 | 8 | C1458155 | |
| Disease | COVID-19 (is_implicated_in) | 4.67e-03 | 21 | 144 | 2 | DOID:0080600 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DPEKLAQELAASLTR | 586 | Q8N6Y0 | |
| NELLSPLKDSDEIRS | 751 | P51826 | |
| VLSLATQDSDNPDLR | 506 | P63010 | |
| KSLPESSLTDLLSDN | 876 | Q2NKJ3 | |
| DDFSPTSKLQRLLAE | 626 | Q6P9F0 | |
| PQDFLDRLSSLDNLK | 526 | Q07065 | |
| LDSSQPSLSKDLRDE | 901 | Q6ZN30 | |
| ITALDLNPERTELLS | 491 | Q676U5 | |
| SDNPLDIAVTRLADL | 1866 | Q9UIF8 | |
| RTLLASPSNEVNLLD | 51 | P54756 | |
| DLDRQSLSSIDKNPS | 1506 | Q9Y6D5 | |
| PASLRQELEDTISSL | 916 | Q8N8E3 | |
| ELNLDVSLQLPSRSS | 1291 | P01024 | |
| VLSLATQDSDNPDLR | 506 | Q10567 | |
| REKQAPELSLSSQDL | 246 | O00273 | |
| LPEDQLRNLFDSIKS | 226 | Q9UIA0 | |
| RTLLQAALSTDPLDA | 771 | Q8NB46 | |
| SSLNPSSRDELLQLL | 76 | Q9NUG4 | |
| ALSSIALAAEDPVRT | 1161 | Q00975 | |
| RASSDLLSDLPTGKN | 386 | Q8N0U7 | |
| LPDGSLRILNASKSD | 531 | O94779 | |
| RELLSLPATSLADQD | 281 | Q8N3Y3 | |
| DPRPELQATADLLSS | 151 | Q8N6L0 | |
| NLLDLEETAKAPLST | 211 | Q5SW96 | |
| PAELLEALNTLSEAK | 286 | Q8N7Z5 | |
| SLTDVSLALSELRPN | 116 | Q96GW7 | |
| TSDILDARKTNELPS | 2351 | Q8WXI7 | |
| EDINQESAPKASLRL | 701 | Q14566 | |
| RLSVELDTAPTLDLN | 241 | Q6A162 | |
| QLTDRSEISLLPSDI | 611 | P43304 | |
| LLANEKSDNSDIRPS | 2921 | Q8NEZ4 | |
| ALNRDLSTPGLEKDS | 1846 | P46821 | |
| SLLPKDAQLSLNTLD | 701 | Q3T906 | |
| SSLLSDVSILPNRAE | 216 | Q6ZRS4 | |
| QESLDALRALPEASL | 226 | O95714 | |
| AQLSDRISLDRSIPD | 121 | Q9HCQ5 | |
| AVSDPSILDSLDLNE | 156 | P05198 | |
| ERLGDSIPKSLSDSL | 1516 | O60333 | |
| TNLAALSLDSLVAPD | 436 | Q9UKG1 | |
| SFDTPDDSIRNKLIL | 441 | P80404 | |
| DSLQPATDLLTRSEL | 406 | Q8WW38 | |
| SANISLEFDLELRPS | 116 | Q9BQP9 | |
| ALPSDDRITNILDSI | 786 | O43593 | |
| TPLNTALNLEKDSDL | 1706 | Q14766 | |
| SLASQLKSEELNLPE | 361 | Q92614 | |
| SAEDLLRLTSKSLPD | 421 | O15018 | |
| LEARNSSEKLPTELS | 266 | P38432 | |
| DDLNLSTSEALRIDP | 356 | P23743 | |
| SLTALEKENQEPLRS | 666 | P48681 | |
| SQPQLLALLDSATER | 1151 | Q86UK5 | |
| PIRLTADLSAETLQA | 246 | Q9UN81 | |
| ALPALSRTTELQDEL | 121 | Q9H019 | |
| TELTDLLKARNSPDL | 146 | Q96PP8 | |
| RALSISPLSDASLDL | 81 | P08151 | |
| SPLSDASLDLQTVIR | 86 | P08151 | |
| RALSISPLSDASLDL | 231 | P10070 | |
| LPLRDRQDLATEDTS | 896 | Q9UMN6 | |
| APENLTLLAETADAR | 156 | Q9ULI3 | |
| TLLQSLAIEDSRDKP | 1141 | Q9Y4D8 | |
| ELLIDLERPQSNSSA | 1111 | Q9C091 | |
| EVARLLASSDPLAQI | 26 | P34949 | |
| QRSLSELESLKLPAE | 236 | P22059 | |
| TPDTLLNILKNADLS | 411 | P51956 | |
| ISDALPSEEVLRSLN | 176 | Q15256 | |
| RDLKLLVTASDSGNP | 526 | Q9Y5H0 | |
| DQEATSPRLSRELLD | 396 | Q9H094 | |
| DSLNLTSPLRIVALD | 416 | Q96QU1 | |
| EPLLALDVDSTNSRL | 531 | Q99572 | |
| SIISDSSALEDLRNP | 1431 | P38398 | |
| TLLSSQKEAEELLPA | 11 | Q14674 | |
| AVDAAEALALSSPLR | 96 | Q6U949 | |
| NLAADSLLPSLLERA | 196 | Q96HP0 | |
| LDKLLDLNPASRITA | 546 | O00311 | |
| DLNPASRITAEEALL | 551 | O00311 | |
| LSPSQADSQLDLLSR | 546 | Q9BQN1 | |
| LDDSNRPASLTKDRL | 556 | Q9NYF8 | |
| SRSLDDALKLTEQPE | 91 | P00374 | |
| RDSDSLLSLRPLNID | 96 | P26998 | |
| LDNSPLVIRATDADS | 1791 | Q8TDW7 | |
| ELSSLASQPLSRLLD | 241 | Q9H665 | |
| KQADSDIPLDRLTIS | 66 | Q14197 | |
| AAASEPSLDLDNLKL | 191 | Q13873 | |
| LELDSLRSQPDASKE | 126 | Q5T5S1 | |
| EENAESLSSTLPLRR | 691 | Q6ZMT9 | |
| LKELSLQASLARPEA | 111 | Q9P203 | |
| NNKISRLLDSLPSDT | 271 | P05155 | |
| TLEPRLSQDLEALLS | 141 | Q76NI1 | |
| LALPQSDASLLSRDE | 11 | Q9H583 | |
| ASSLPRVDDVLASLQ | 646 | Q92503 | |
| SLLSESQLKEALEPN | 26 | O15259 | |
| RLNLSSNELKSLPAE | 201 | Q9H9A6 | |
| ALERKNSAIPSELNE | 336 | Q96CV9 | |
| ASPKAAEAARLLLSD | 696 | Q13835 | |
| LDNLLTIAPRDTAKA | 1621 | Q86VV8 | |
| TELPARSIDLSALNL | 66 | C9JL84 | |
| QDLLLGPSESNDRLS | 421 | Q9NRF2 | |
| LDSKDNSESQLRIPL | 1196 | Q9C093 | |
| SAVRDEDPLELANTL | 271 | Q6P1N9 | |
| SSPQKVALTLDLDLE | 251 | Q14542 | |
| DQPLSLTLAALRENT | 741 | Q93075 | |
| QKLRELDPSLVSAND | 2146 | Q5UIP0 | |
| DEKDLRSTPNLSLDD | 756 | Q15788 | |
| LPASLERALTEDSTQ | 316 | P21462 | |
| SDIAPNDTTRDLILL | 311 | O75343 | |
| LRELDLPSQDNVSLT | 121 | Q96CC6 | |
| LTDTASPQLLDPADR | 411 | P81133 | |
| TLLNPTELNRDIADS | 626 | Q9UIU6 | |
| SLRLDPTLSVDDLAN | 401 | P37173 | |
| IRQSLDLFLPDKTAS | 46 | Q9NWS8 | |
| LDLAVPETARLDSSL | 16 | Q8IZD0 | |
| SLNVADLTSLRAPLD | 51 | Q9UL46 | |
| LLDELIKPTSLASDN | 146 | O75925 | |
| LDEALLAKSPANLSE | 391 | Q9UPG8 | |
| SISDLSLQLKNRDPE | 2316 | Q9NRC6 | |
| PLSDLQEEAASASLR | 11 | Q96F83 | |
| LPELSRVEANSTLLN | 251 | Q9UHD1 | |
| DLLPEAASLSENLDI | 1051 | A0JNW5 | |
| LDPLASEDTSRQKAI | 76 | O95229 | |
| NEDLAEVASLPRLES | 176 | Q9C0D3 | |
| EVASLPRLESLDISN | 181 | Q9C0D3 | |
| PLSESKNRLLDSESQ | 326 | Q5W0Z9 | |
| SDSDLFSRDQKSLLP | 986 | Q8IVF5 | |
| LEELQLANSAKLSDP | 571 | Q13496 | |
| LLSPSSAAEALELNL | 186 | Q96PV0 | |
| SPALSLSSLRSDDLQ | 576 | Q8IWN7 | |
| ELREDSPAARSLSLQ | 46 | Q9BXM0 | |
| DSSELLDSDALNRPL | 156 | O14787 | |
| AAALSQALRLEAPEL | 51 | Q8IZQ5 | |
| KDISSALRVNPALAE | 46 | P13489 | |
| PERALNSALAEEITL | 541 | Q6ZSY5 | |
| DSNSSLILRPLTKEA | 466 | Q9P2J2 | |
| DLRNINLSSSKLEPS | 596 | Q8N841 | |
| KENASPSELRDLLSE | 761 | P07949 | |
| DNKRSTLLPEDFNLI | 566 | Q8NEG5 | |
| RDSNAAPLLEILTDQ | 361 | A7E2V4 | |
| LEDISDLASELSQAP | 291 | O95049 | |
| SLLTNEPVKRDSLAS | 226 | Q86YA3 | |
| EDARLSPEKSLQLAS | 1446 | Q96JM2 | |
| PSLARSALEKNLADA | 691 | A3KMH1 | |
| RDLQSLAEVDAPDLS | 361 | A8MYJ7 | |
| KLDSFLSEARSLLNP | 1866 | Q5VUA4 | |
| SDTLEALLLTASERP | 161 | Q9NYU2 | |
| LQPDSQDDKASSRLL | 1881 | O75962 | |
| ESPLLRASKENDLSV | 46 | Q9NQA5 | |
| LRSNVLLSFDDTPEK | 916 | P49815 | |
| VKDNSSLNPLDRLIS | 836 | Q7Z570 | |
| IIRSAPATELLDSSN | 976 | Q5EBL2 | |
| LEALLRNSAAPSKDD | 281 | Q8NAP8 | |
| ALRSLVLAENSISPE | 231 | Q5JTD7 | |
| LPTDIVLLLRSSDNS | 851 | Q8NEV4 | |
| SLAPRKLNSTSDIEE | 496 | O60237 |